Regulatory Approvals

Galaxy Therapeutics lands CE mark for Seal embolisation system

By

Regulatory Approvals — Galaxy Therapeutics lands CE mark for Seal embolisation system  NeuroNews International

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 4, 2026.

By

Related Post

Regulatory Approvals

Tip Sheet: Experts discover fibromyalgia risk factors; FDA approves new breast cancer drug — and public health genome platform expands to new phase

Regulatory Approvals

FDA approves Charlotte company’s drug for cardiac disorder affecting thousands of patients

Regulatory Approvals

FDA Clears Rituximab Biosimilar, Expanding Options for B-Cell Malignancies

Financial News For All

Mergers & Acquisitions

Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher

Mergers & Acquisitions

Antitrust Trial Over Paramount-Warner Merger Set for March

Labor

Tensions flare as public defender strike heads into second week

Labor

Tech companies chop several hundred Bay Area jobs in fresh layoffs